165 related articles for article (PubMed ID: 36539726)
1. Determinants of cervical cancer screening utilization among women attending health facilities of Dessie town, Northeast Ethiopia.
Assefa T; Arefaynie M; Mebratu W; Mohammed A; Addisu E; Kebede N
BMC Cancer; 2022 Dec; 22(1):1330. PubMed ID: 36539726
[TBL] [Abstract][Full Text] [Related]
2. Determinants of cervical cancer screening service utilization among women attending healthcare services in Amhara region referral hospitals: a case-control study.
Legasu TD; Temesgen K; Ayele ZT; Chekole MS; Bayou FD; Fetene JC; Tibebu AT; Taye BT; Ali MA
BMC Womens Health; 2022 Dec; 22(1):484. PubMed ID: 36461054
[TBL] [Abstract][Full Text] [Related]
3. Cervical cancer screening service utilization and associated factors among HIV positive women attending adult ART clinic in public health facilities, Hawassa town, Ethiopia: a cross-sectional study.
Assefa AA; Astawesegn FH; Eshetu B
BMC Health Serv Res; 2019 Nov; 19(1):847. PubMed ID: 31744548
[TBL] [Abstract][Full Text] [Related]
4. Cervical Cancer Screening Utilization and Associated Factors Among Women Aged 30 to 49 Years in Dire Dawa, Eastern Ethiopia.
Belay Y; Dheresa M; Sema A; Desalew A; Assefa N
Cancer Control; 2020; 27(1):1073274820958701. PubMed ID: 33034204
[TBL] [Abstract][Full Text] [Related]
5. Utilization of cervical cancer screening and associated factors among women in Debremarkos town, Amhara region, Northwest Ethiopia: Community based cross-sectional study.
Aynalem BY; Anteneh KT; Enyew MM
PLoS One; 2020; 15(4):e0231307. PubMed ID: 32255807
[TBL] [Abstract][Full Text] [Related]
6. Cervical cancer screening service utilization and associated factors among age-eligible women in Jimma town using health belief model, South West Ethiopia.
Nigussie T; Admassu B; Nigussie A
BMC Womens Health; 2019 Oct; 19(1):127. PubMed ID: 31660938
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive knowledge on cervical cancer, attitude towards its screening and associated factors among women aged 30-49 years in Finote Selam town, northwest Ethiopia.
Geremew AB; Gelagay AA; Azale T
Reprod Health; 2018 Feb; 15(1):29. PubMed ID: 29444689
[TBL] [Abstract][Full Text] [Related]
8. Cervical cancer screening uptake and determinant factors among women in Ambo town, Western Oromia, Ethiopia: Community-based cross-sectional study.
Natae SF; Nigatu DT; Negawo MK; Mengesha WW
Cancer Med; 2021 Dec; 10(23):8651-8661. PubMed ID: 34704666
[TBL] [Abstract][Full Text] [Related]
9. Determinants of cervical cancer screening utilization among HIV-positive women, in public general hospitals of Central Zone, Tigray, Ethiopia, 2020: Case-control study.
Gebremeskel TG; Gebretatios MZ
PLoS One; 2023; 18(12):e0289042. PubMed ID: 38085714
[TBL] [Abstract][Full Text] [Related]
10. Cervical cancer screening utilization and associated factors among female health workers in public health facilities of Hossana town, southern Ethiopia: A mixed method approach.
Jemal Z; Chea N; Hasen H; Tesfaye T; Abera N
PLoS One; 2023; 18(5):e0286262. PubMed ID: 37252937
[TBL] [Abstract][Full Text] [Related]
11. Utilization and associated factors of cervical cancer screening service among eligible women attending maternal health services at Adare General Hospital, Hawassa city, Southern Ethiopia.
Assefa AA; Feleke T; G/Tsadik SA; Degela F; Zenebe A; Abera G
Sci Rep; 2024 Feb; 14(1):2774. PubMed ID: 38307895
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening utilization and associated factors among women attending antenatal care at Asella Referral and Teaching Hospital, Arsi zone, South Central Ethiopia.
Shero AA; Kaso AW; Tafa M; Agero G; Abdeta G; Hailu A
BMC Womens Health; 2023 Apr; 23(1):199. PubMed ID: 37118809
[TBL] [Abstract][Full Text] [Related]
13. Uptake of pre-cervical cancer screening and associated factors among reproductive age women in Debre Markos town, Northwest Ethiopia, 2017.
Bante SA; Getie SA; Getu AA; Mulatu K; Fenta SL
BMC Public Health; 2019 Aug; 19(1):1102. PubMed ID: 31412831
[TBL] [Abstract][Full Text] [Related]
14. Determinants of utilization of cervical cancer screening among women in the age group of 30-49 years in Ambo Town, Central Ethiopia: A case-control study.
Lemma D; Aboma M; Girma T; Dechesa A
PLoS One; 2022; 17(7):e0270821. PubMed ID: 35830438
[TBL] [Abstract][Full Text] [Related]
15. Precancerous lesion determinants in women attending cervical cancer screening at public health facilities in North Shoa Zone, Amhara, Ethiopia: an unmatched case-control study.
Teklehaimanot DA; Mekuria AD; Dadi AF; Derseh BT
BMC Womens Health; 2024 May; 24(1):271. PubMed ID: 38702683
[TBL] [Abstract][Full Text] [Related]
16. Predictors of cervical cancer screening practice among HIV positive women attending adult anti-retroviral treatment clinics in Bishoftu town, Ethiopia: the application of a health belief model.
Solomon K; Tamire M; Kaba M
BMC Cancer; 2019 Oct; 19(1):989. PubMed ID: 31646975
[TBL] [Abstract][Full Text] [Related]
17. Knowledge and practice of cervical cancer screening and its associated factors among women attending maternal health services at public health institutions in Assosa Zone, Benishangul-Gumuz, Northwest Ethiopia, 2022: a cross-sectional study.
Gelassa FR; Nagari SL; Jebena DE; Belgafo D; Teso D; Teshome D
BMJ Open; 2023 May; 13(5):e068860. PubMed ID: 37188474
[TBL] [Abstract][Full Text] [Related]
18. Factors affecting utilization of cervical cancer screening services among women attending public hospitals in Tigray region, Ethiopia, 2018; Case control study.
Teame H; Gebremariam L; Kahsay T; Berhe K; Gebreheat G; Gebremariam G
PLoS One; 2019; 14(3):e0213546. PubMed ID: 30870497
[TBL] [Abstract][Full Text] [Related]
19. Uptake of Cervical Cancer Screening and Associated Factors Among 15-49-Year-Old Women in Dessie Town, Northeast Ethiopia.
Tefera F; Mitiku I
J Cancer Educ; 2017 Dec; 32(4):901-907. PubMed ID: 27075197
[TBL] [Abstract][Full Text] [Related]
20. Determinants of Cervical Cancer Screening Service Utilization Among HIV-Positive Women Aged 25 Years and Above Attending Adult ART Clinics in Southern Tigray, Ethiopia.
Gebrekirstos LG; Gebremedhin MH; Tafesse TT; Tura TS; Geleso MG; Wube TB
Cancer Control; 2022; 29():10732748221126944. PubMed ID: 36112936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
